GoalVest Advisory’s CME Group CME Stock Holding History

GoalVest Advisory’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$90.6K	Sell	346 -12	-3%	-$3.16K	0.02%	174
2026 Q2	$79.1K	Sell	358 -362	-50%	-$100K	0.01%	174
2026 Q1	$213K	Buy	720 +18	+3%	+$5.35K	0.04%	144
2025 Q4	$192K	Buy	702 +263	+60%	+$71.5K	0.04%	149
2025 Q3	$119K	Hold	439	–	–	0.03%	160
2025 Q2	$121K	Buy	439 +177	+68%	+$48.1K	0.03%	157
2025 Q1	$69.5K	Buy	262 +101	+63%	+$24.9K	0.02%	161
2024 Q4	$37.4K	Hold	161	–	–	0.01%	202
2024 Q3	$35.5K	Buy	161 +111	+222%	+$23K	0.01%	218
2024 Q2	$9.8K	Sell	50 -85	-63%	-$17.6K	﹤0.01%	276
2024 Q1	$29.1K	Sell	135 -65	-33%	-$13.7K	0.01%	233
2023 Q4	$42.1K	Buy	200 +185	+1,233%	+$39.5K	0.02%	148
2023 Q3	$3K	Buy	+15	New	+$2.98K	﹤0.01%	389
2023 Q2	–	Sell	-60	Closed	-$11.5K	–	370
2023 Q1	$11.5K	Hold	60	–	–	0.01%	182
2022 Q4	$10.1K	Hold	60	–	–	0.01%	183
2022 Q3	$11K	Hold	60	–	–	0.01%	181
2022 Q2	$12K	Hold	60	–	–	0.01%	247
2022 Q1	$14K	Buy	+60	New	+$14.1K	0.01%	217
2021 Q1	–	Sell	-60	Closed	-$11K	–	180
2020 Q4	$11K	Buy	+60	New	+$10.2K	0.01%	164

Other funds holding CME

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

GoalVest Advisory's CME Position: Q3 2026 in Review

GoalVest Advisory reduced its CME Group (CME) stake by 3.4% in Q3 2026, selling an estimated $3.16K and leaving 346 shares worth $90.6K. The position accounts for 0.02% of the portfolio, ranked #174.

GoalVest Advisory first reported a position in CME in Q4 2020 and has held it in 19 quarters since. The position peaked at $213K in Q1 2026. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

GoalVest Advisory held 346 shares of CME Group worth $90.6K as of Q3 2026.
GoalVest Advisory sold 12 CME Group shares in Q3 2026, an estimated $3.16K.
CME Group made up 0.02% of GoalVest Advisory's portfolio in Q3 2026, its #174 holding.
GoalVest Advisory first reported a position in CME Group in Q4 2020 and has held it in 19 quarters since.
GoalVest Advisory's CME Group position peaked at $213K in Q1 2026.
1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on GoalVest Advisory's 13F filing for Q3 2026, filed 2 Oct 2026.